VCP
ELV icon

Vernier Capital Partners’s Elevance Health ELV Stock Holding History

Vernier Capital Partners’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-24,000
Closed -$5.4M – 21
2017
Q4 		$5.4M Buy
+24,000
New +$5.11M 2.88% 20

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Vernier Capital Partners's ELV Position: Q1 2018 in Review

Vernier Capital Partners sold out of Elevance Health (ELV) in Q1 2018, closing a stake of 24,000 shares — an estimated $5.4M sold.

Vernier Capital Partners first reported a position in ELV in Q4 2017 and held it in 1 quarter. The position peaked at $5.4M in Q4 2017. 922 funds tracked by Wall St. Rank hold ELV as of Q1 2018.

  • Vernier Capital Partners reported no remaining Elevance Health position as of Q1 2018 after selling out during the quarter.
  • Vernier Capital Partners sold 24,000 Elevance Health shares in Q1 2018, an estimated $5.4M.
  • Vernier Capital Partners first reported a position in Elevance Health in Q4 2017 and held it in 1 quarter.
  • Vernier Capital Partners's Elevance Health position peaked at $5.4M in Q4 2017.
  • 922 funds tracked by Wall St. Rank held Elevance Health as of Q1 2018.

Based on Vernier Capital Partners's 13F filing for Q1 2018, filed 15 May 2018.